164 related articles for article (PubMed ID: 15668707)
1. P53 abnormalities and outcomes in colorectal cancer: a systematic review.
Munro AJ; Lain S; Lane DP
Br J Cancer; 2005 Feb; 92(3):434-44. PubMed ID: 15668707
[TBL] [Abstract][Full Text] [Related]
2. P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation.
Li XL; Zhou J; Chen ZR; Chng WJ
World J Gastroenterol; 2015 Jan; 21(1):84-93. PubMed ID: 25574081
[TBL] [Abstract][Full Text] [Related]
3. The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review.
Smorodin E; Chuzmarov V; Veidebaum T
Curr Oncol; 2024 Apr; 31(4):1994-2023. PubMed ID: 38668052
[TBL] [Abstract][Full Text] [Related]
4. Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients.
Cheng B; Xu L; Zhang Y; Yang H; Liu S; Ding S; Zhao H; Sui Y; Wang C; Quan L; Liu J; Liu Y; Wang H; Zheng Z; Wu X; Guo J; Wen Z; Zhang R; Wang F; Liu H; Sun S
Heliyon; 2024 Apr; 10(7):e29299. PubMed ID: 38623252
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in precision oncology.
Tomasik B; Garbicz F; Braun M; Bieńkowski M; Jassem J
Camb Prism Precis Med; 2024; 2():e2. PubMed ID: 38549846
[TBL] [Abstract][Full Text] [Related]
6. A Second Career for p53 as A Broad-Spectrum Antiviral?
Harford JB
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140618
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques.
Kasprzak A
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760539
[TBL] [Abstract][Full Text] [Related]
8. APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy.
Xie X; Fan C; Luo B; Zhang J; Jensen LD; Burman J; Jönsson C; Ljusberg A; Larsson P; Zhao Z; Sun XF
Mol Cancer Ther; 2023 Aug; 22(8):947-961. PubMed ID: 37216282
[TBL] [Abstract][Full Text] [Related]
9. Mutant pattern of p53 predicts local recurrence and poor survival rate in gastric cancer.
Chung Y; Lee HW; Park JH; Yoo CH; Son BH; Kim K
Histol Histopathol; 2023 Sep; 38(9):999-1007. PubMed ID: 36847420
[TBL] [Abstract][Full Text] [Related]
10. A Variable-Clustering-Based Feature Selection to Improve Positive and Negative Discrimination of P53 Protein in Colorectal Cancer Patients.
Wang L; Feng L; Wang J; Li J; Li H; Zeng F; Sun L
Comput Math Methods Med; 2022; 2022():9261713. PubMed ID: 36439951
[TBL] [Abstract][Full Text] [Related]
11. Presence of Concurrent
Wang C; Sandhu J; Tsao A; Fakih M
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892903
[TBL] [Abstract][Full Text] [Related]
12. Mutations in TP53 and PIK3CA genes in hepatocellular carcinoma patients are associated with chronic Schistosomiasis.
AlGabbani Q
Saudi J Biol Sci; 2022 Feb; 29(2):848-853. PubMed ID: 35197752
[TBL] [Abstract][Full Text] [Related]
13. Wild-Type TP53 Predicts Poor Prognosis in Patients with Gastric Cancer.
Deng W; Hao Q; Vadgama J; Wu Y
J Cancer Sci Clin Ther; 2021 Mar; 5(1):134-153. PubMed ID: 34950877
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Hasbullah HH; Musa M
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769370
[TBL] [Abstract][Full Text] [Related]
15. Profiling Colorectal Cancer in the Landscape Personalized Testing-Advantages of Liquid Biopsy.
Verbanac D; Čeri A; Hlapčić I; Shakibaei M; Brockmueller A; Krušlin B; Ljubičić N; Baršić N; Detel D; Batičić L; Rumora L; Somborac-Bačura A; Štefanović M; Ćelap I; Demirović A; Petlevski R; Petrik J; Grdić Rajković M; Hulina-Tomašković A; Rako I; Saso L; Barišić K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919272
[TBL] [Abstract][Full Text] [Related]
16. Molecular features and gene expression signature of metastatic colorectal cancer (Review).
Poturnajova M; Furielova T; Balintova S; Schmidtova S; Kucerova L; Matuskova M
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649827
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors.
Hegde M; Joshi MB
J Cancer Res Clin Oncol; 2021 Apr; 147(4):937-971. PubMed ID: 33604794
[TBL] [Abstract][Full Text] [Related]
18. Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway.
Xie H; Ma K; Zhang K; Zhou J; Li L; Yang W; Gong Y; Cai L; Gong K
Cell Death Dis; 2021 Jan; 12(1):1. PubMed ID: 33414393
[TBL] [Abstract][Full Text] [Related]
19. Precision medicine for adjuvant chemotherapy of resected colorectal cancer.
Miyamoto Y; Hiyoshi Y; Sawayama H; Tokunaga R; Baba H
Ann Gastroenterol Surg; 2020 Nov; 4(6):635-645. PubMed ID: 33319153
[TBL] [Abstract][Full Text] [Related]
20. Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer.
Chen M; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Xue F; Huang Y
Int J Med Sci; 2020; 17(17):2744-2750. PubMed ID: 33162802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
